CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websiteeisai.co.jp
CategoryBioTech
Phone81(3)3817-5327
Employees

Offices

Tokyo , JPN
4-6-10 Koishikawa, Bunkyo-ku
Tokyo , 112-8088, JPN

Acquisitions

AkaRx, 1/10 $255M

Tags

Eisai

Eisai Co. place primary emphasis on patients and their families, they strive to increase the benefits that health care provides them and they conduct their business to meet their diversified health care needs worldwide. They aim to be Human Health Care (“hhc”) companies that make a meaningful contribution under any health care system through their business activities around the world.

Recent Milestones

  • Check
    Eisai — H3 Biomedicine launches with $200M from Eisai (1/28/11)
    Posted 1/30/11 at 11:15pm via masshightech.com
  • Handshake
    Eisai acquired AkaRx for $255M. (1/7/10)
    Posted 1/13/10 at 4:42am via co.jp

Videos

Screenshots

Eisai screenshot
Above: Eisai Co.
Uploaded: 1/13/10

Sources

  1. Eisai Completes Acquisition of AkaRx, Inc. in the United States (eisai.co.jp) [edit]
  2. H3 Biomedicine launches with $200M from Eisai (masshightech.com) [edit]
Edit This Page
Last Edited 3/10/11

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy